Sumavel dosepro and Metformin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumavel dosepro (sumatriptan succinate) and Metformin (metformin hydrochloride). Common drug interactions include arthritis among females and injection site haemorrhage among males.

The phase IV clinical study analyzes what interactions people have when they take Sumavel dosepro and Metformin. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Sumavel dosepro?

Sumavel dosepro has active ingredients of sumatriptan succinate. eHealthMe is studying from 1,276 Sumavel dosepro users. Check the latest studies of Sumavel dosepro.

What is Metformin?

Metformin has active ingredients of metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 465,354 Metformin users. Check the latest studies of Metformin.

On Jul, 30, 2026

22 people who take Sumavel dosepro and Metformin together, and have interactions are studied.

Sumavel dosepro and Metformin drug interactions.

What are the common drug interactions of Sumavel Dosepro and Metformin, by gender? *:

female:

Arthritis (form of joint disorder that involves inflammation of one or more joints)
Back pain
Blood pressure increased
Dry eye (lack of adequate tears)
Dyspepsia (indigestion)
Faeces discoloured
Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
Hypertension (high blood pressure)
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)

male:

Injection site haemorrhage (bleeding from injection site)
Injection site bruising
Injection site pain
Injection site scar

What are the common drug interactions of Sumavel Dosepro and Metformin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Drug ineffective
Headache (pain in head)
Malaise (a feeling of general discomfort or uneasiness)
Vomiting

40-49:

Dizziness
Injection site pain
Pain of skin
Dermal cyst
Disability
Injection site bruising
Injection site induration

50-59:

Arthritis (form of joint disorder that involves inflammation of one or more joints)
Back pain
Dry eye (lack of adequate tears)
Dyspepsia (indigestion)
Faeces discoloured
Fall
Hypertension (high blood pressure)
Asthma
Cough
Migraine (headache)

60+:

Drug effect decreased
Fall
Head injury
Headache (pain in head)
Limb injury
Nausea (feeling of having an urge to vomit)
Swelling face
Weight increased

What are the existing conditions these people have? *

Migraine (headache): 15 people, 68.18%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 18.18%
Hypersensitivity: 4 people, 18.18%
High Blood Pressure: 4 people, 18.18%
High Blood Cholesterol: 4 people, 18.18%
Sleep Disorder: 3 people, 13.64%
Pain: 3 people, 13.64%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 13.64%
Vulvovaginal Dryness: 2 people, 9.09%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Sumavel dosepro and Metformin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously